Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations
| dc.contributor.author | Umit, Elif Gulsum | |
| dc.contributor.author | Demir, Ahmet Muzaffer | |
| dc.contributor.author | Ar, Muhlis Cem | |
| dc.contributor.author | Ayer, Mesut | |
| dc.contributor.author | Ayli, Meltem | |
| dc.contributor.author | Karakus, Volkan | |
| dc.contributor.author | Kaya, Emin | |
| dc.date.accessioned | 2026-04-04T13:30:49Z | |
| dc.date.available | 2026-04-04T13:30:49Z | |
| dc.date.issued | 2024 | |
| dc.department | İnönü Üniversitesi | |
| dc.description.abstract | Objective: Primary immune thrombocytopenia (ITP) is an acquired disorder of platelets with a complex and unclear mechanism of increased immune destruction or impaired production of platelets. While the management of ITP is evolving, there is still a need for guidance, particularly in certain circumstances such as pregnancy, emergencies, or patients requiring co-medications. We aimed to determine the tendencies of hematologists in T & uuml;rkiye in the event of such special considerations. Materials and Methods: Applying a modified Delphi method, the Turkish National ITP Working Group, founded under the auspices of the Turkish Society of Hematology, developed a questionnaire consisting of statements regarding pregnancy, emergencies, and circumstances requiring co-treatment with antiaggregants or anticoagulants. A total of 107 hematologists working in university or state hospitals voted for their agreement or disagreement with the statements for two sequential rounds. Results: The participating hematologists reached an agreement on starting treatment for pregnant patients with platelets of less than 30x109/L 9 /L and delivery either vaginally or by cesarean section being safe at platelet counts above 50x109/L. 9 /L. For emergencies and the rescue management of ITP, the panel agreed against the use of high-dose corticosteroids alone, preferring combinations with transfusions or intravenous immunoglobulin. For patients who require interventions, platelet counts of >50x109/L 9 /L were regarded as safe for low-risk procedures as well as co-treatment with antiplatelets or anticoagulants. Conclusion: As the National ITP Study Group, we have observed the need to increase the practice guidance regarding patients with primary ITP requiring additional treatments including invasive interventions and co-treatments for coagulation. Decisions on the management of ITP during pregnancy should be individualized. There is a lack of consensus on the thresholds of platelet counts as well as co-morbidities and co-medications. This lack of consensus may be due to variations in practices. | |
| dc.description.sponsorship | Abdi Idot;brahim Pharmaceuticals | |
| dc.description.sponsorship | This study was financially supported by Abdi & Idot;brahim Pharmaceuticals. | |
| dc.identifier.doi | 10.4274/tjh.galenos.2024.2024.0101 | |
| dc.identifier.endpage | 145 | |
| dc.identifier.issn | 1300-7777 | |
| dc.identifier.issn | 1308-5263 | |
| dc.identifier.issue | 3 | |
| dc.identifier.orcid | 0000-0001-8605-8497 | |
| dc.identifier.orcid | 0000-0003-1977-0104 | |
| dc.identifier.pmid | 38801066 | |
| dc.identifier.scopus | 2-s2.0-85202791501 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 141 | |
| dc.identifier.trdizinid | 1315674 | |
| dc.identifier.uri | https://doi.org/10.4274/tjh.galenos.2024.2024.0101 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1315674 | |
| dc.identifier.uri | https://hdl.handle.net/11616/108389 | |
| dc.identifier.volume | 41 | |
| dc.identifier.wos | WOS:001301331900002 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Galenos Publ House | |
| dc.relation.ispartof | Turkish Journal of Hematology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20250329 | |
| dc.subject | Adult primary immune thrombocytopenia | |
| dc.subject | Management | |
| dc.subject | Delphi method | |
| dc.subject | Special considerations | |
| dc.title | Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations | |
| dc.type | Article |











